- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02367092
Exercise Intervention in Liver Transplant Patients
September 2, 2022 updated by: University of California, San Francisco
The purpose of this study is to learn more about the effects of exercise on functional status and outcomes on patients with end-stage liver disease on the liver transplant waiting list and who have undergone liver transplantation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study aims to evaluate the effects of a home-based exercise intervention on outcomes in liver transplant candidates and recipients.
This home-based intervention consists of a 30-minute exercise session available on digital video disc or on the internet.
This intervention was originally developed to improve functional status in community-dwelling older adults and therefore, has been designed to maximize the safety for even the most frail individuals.
Subjects enrolled in this study will be randomized to one of two arms: (a) the exercise intervention arm in which the subjects will be asked perform this exercise session three to four times per week or (b) the standard-of-care arm in which the patient will be encouraged to exercise by their transplant clinician at every clinic visit.
Subjects in the exercise intervention arm will undergo this intervention for 6 months.
All subjects will be followed for up to two years from the time of enrollment to ascertain outcomes.
Study Type
Interventional
Enrollment (Actual)
83
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California, San Francisco
-
-
Maryland
-
Baltimore, Maryland, United States, 21218
- Johns Hopkins University
-
-
North Carolina
-
Durham, North Carolina, United States, 27708
- Duke University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult (>=18 years of age)
- Listed for liver transplantation or post-liver transplantation
- English speaking
Exclusion Criteria:
- Contraindications to weight-bearing exercise
- Non-English speaking
- Requires an assistive device for ambulation
- Active hepatic encephalopathy at the time of baseline assessment for enrollment in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Exercise Program
The exercise intervention consists of a 30 minute exercise session led by an instructor through a DVD or a video available on the internet.
|
They will perform low-intensity, low-resistance exercise facilitated by a DVD video in their home.
This exercise program lasts for 30 minutes at a time.
Patients will be instructed to engage in this exercise program 3-4 times per week but not more often than 4 times per week.
Pre-transplant patients will be asked to do the exercises from enrollment to transplant.
Post-transplant patients will be asked to do the exercises for 6 months.
|
|
No Intervention: Standard of care
Standard of care which consists of encouragement to exercise by the subject's transplant clinician.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Liver Frailty Index
Time Frame: 12 and 24 weeks after enrollment
|
Liver Frailty Index as measured by score in functional assessments of grip strength (kg), balance (seconds), and chair stands (seconds).
|
12 and 24 weeks after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality at 24 weeks
Time Frame: 1 year
|
Mortality status at 24 weeks
|
1 year
|
|
Hospitalized days at 24 weeks
Time Frame: 1 year
|
Number of days in the hospital from baseline to 24 weeks
|
1 year
|
|
Quality of Life by CLDQ
Time Frame: 12 and 24 weeks after enrollment
|
Quality of life assessed by the CLDQ at 12 and 24 weeks after enrollment
|
12 and 24 weeks after enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle. 2012 Dec;3(4):225-37. doi: 10.1007/s13539-012-0069-3. Epub 2012 May 31.
- Jones JC, Coombes JS, Macdonald GA. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl. 2012 Feb;18(2):146-51. doi: 10.1002/lt.22472.
- Murray KF, Carithers RL Jr; AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology. 2005 Jun;41(6):1407-32. doi: 10.1002/hep.20704. No abstract available.
- Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant. 2014 Aug;14(8):1870-9. doi: 10.1111/ajt.12762. Epub 2014 Jun 16.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (Actual)
December 1, 2019
Study Completion (Actual)
December 1, 2019
Study Registration Dates
First Submitted
December 20, 2014
First Submitted That Met QC Criteria
February 12, 2015
First Posted (Estimate)
February 20, 2015
Study Record Updates
Last Update Posted (Actual)
September 7, 2022
Last Update Submitted That Met QC Criteria
September 2, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-14783
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End Stage Liver Disease
-
Bridge to Life Ltd.Enrolling by invitationLiver Failure | End Stage Liver DIseaseUnited States
-
Vanderbilt University Medical CenterSuspendedEnd Stage Liver DIseaseUnited States
-
Virginia Commonwealth UniversityCompletedEnd Stage Liver DIseaseUnited States
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonCompletedEnd-stage Liver DiseaseUnited Kingdom
-
Proteonomix, Inc.University of Medicine and Dentistry of New Jersey; NumodaUnknownEnd Stage Liver DIseaseUnited States
-
University of ZurichUniversity Ghent; University Hospital of Sao Paulo, BrazilCompleted
-
RenJi HospitalNot yet recruitingEnd Stage Liver DIsease
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Huashan HospitalRecruiting
-
Beijing Chao Yang HospitalUnknownLiver Transplantation | End Stage Liver DIseaseChina
Clinical Trials on Exercise Program
-
Azienda Sanitaria Locale CN1 CuneoRecruiting
-
Kafrelsheikh UniversityRecruitingLow Back Pain | Pilates Exercises | Nonspecific | Postnatal WomenEgypt
-
Hull University Teaching Hospitals NHS TrustTerminated
-
University of Vic - Central University of CataloniaCol·legi Fisioterapeutes de CatalunyaNot yet recruitingBreast Cancer | Physical Activity | Colorectal Cancer | Strength and Endurance | Lung Cancer (Non-Small Cell) | Neoadjuvant Chemotherapy ToleranceSpain
-
Marmara UniversityRecruitingTendinopathy | Shoulder PainTurkey
-
Munzur UniversityRecruiting
-
Akdeniz UniversityCompletedAnkylosing SpondylitisTurkey
-
University of AlexandriaCompleted
-
Chang Gung Memorial HospitalCompleted
-
Rosimeire Simprini PadulaUnknownMusculoskeletal Disorder of the NeckBrazil